Company: LIMN
Filing Date: 2025-07-03
Form Type: 8-K
Source: 0001104659-25-065663
Chunk: 2

Company: Liminatus Pharma, Inc.
Filing Date: 2025-07-03
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01 Financial Statements and Exhibits.

  Exhibit No.      Description                                                  
 ────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (formatted as Inline XBRL)  

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 ───────────────────────────────────────────────────────
  LIMINATUS PHARMA, INC.                               
  By:                         /s/ Chris Kim            
  Name:                       Chris Kim                
  Title:                      Chief Executive Officer